Imago BioSciences

+$0.10 (+0.45%) As of 2:50 PM UTC today

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMGO and other ETFs, options, and stocks.

About IMGO

Imago BioSciences, Inc. operates as a clinical-stage biopharmaceutical company that develops novel anti-cancer therapeutics. It translates science of genetics and epigenetics enzymes into novel medicines for treating myeloid diseases that pose challenges to patients, families, and physicians.

CEO
Hugh Young Rienhoff
Employees
14
Headquarters
South San Francisco, California
Founded
2012

IMGO Key Statistics

Market Cap
789.51M
Price-Earnings Ratio
—
Dividend Yield
—
Average Volume
79.27K
High Today
$24.02
Low Today
$23.19
Open Price
$24.02
Volume
7.79K
52 Week High
$35.68
52 Week Low
$14.99

IMGO Earnings

-$8.13
-$5.42
-$2.71
$0.00
Q2 FY21
Q3 FY21
Estimated
— per share
Actual
Expected Nov 11, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC. Full disclosure